Clinical Trial Update: Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial update on treatment and secondary prevention of venous thromboembolism in adults with solid or hematologic cancers; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Venous Thromboembolism (VTE) | Phase 3 | Status: NOT_YET_RECRUITING